Recent News

• 12.23.2025 - Vaccinex, Inc. Announces $60 million Agreement to Finance a Phase 2b clinical trial of pepinemab to treat Alzheimer’s Disease
• 12.01.2025 - December 1, 2025 - December 4, 2025 : Clinical Trials on Alzheimer's Disease (CTAD) 2025
• 12.01.2025 - December 1, 2025 - December 4, 2025 : Clinical Trials on Alzheimer's Disease (CTAD) 2025
• 11.05.2025 - November 5, 2025 - November 9, 2025 : Society for Immunotherapy of Cancer (SITC) 2025
• 11.05.2025 - November 5, 2025 - November 9, 2025 : Society for Immunotherapy of Cancer (SITC) 2025
• 10.07.2025 - October 7, 2025 - October 9, 2025 : 3rd Fluid & Imaging Biomarkers in Neuroscience Summit
• 10.07.2025 - October 7, 2025 - October 9, 2025 : 3rd Fluid & Imaging Biomarkers in Neuroscience Summit
• 07.27.2025 - July 27, 2025 - July 31, 2025 : Alzheimer's Association International Conference (AAIC)
• 07.27.2025 - July 27, 2025 - July 31, 2025 : Alzheimer's Association International Conference (AAIC)
• 06.16.2025 - June 16, 2025 - June 19, 2025 : BIO International Convention

Recent Filings